Product image of Kacital (Potassium Citrate) supplied by GNH India

Kacital

Active Ingredient:
Potassium Citrate
Origin:
EU

Kacital (Potassium Citrate)

Potassium citrate, the active ingredient in Kacital, is a potassium salt/alkalinizing agent presented as an oral formulation for oral administration. It supplies potassium ions and citrate, helping to correct hypokalemia, alkalinize urine to reduce renal stone formation, and treat metabolic acidosis in patients who need electrolyte supplementation.

GNH India supplies Kacital as a licensed, GDP‑compliant international pharmaceutical supplier, sourcing the product from EU manufacturers and serving hospitals, pharmacies and clinics worldwide with quality‑assured, regulated medication, including comprehensive documentation and support for import compliance.

Manufacturer / TM Owner

Vital Pharma Nordic Aps

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Kacital (potassium citrate) is used to manage electrolyte balance and urinary chemistry disorders.

  • Hypokalemia: restores potassium levels in patients with low serum potassium.
  • Prevention of renal calculi: alkalinizes urine to reduce calcium‑based stone formation.
  • Metabolic acidosis: supplies citrate to buffer excess acid and correct systemic pH.

How It Works

  • Potassium citrate dissociates after oral absorption, releasing potassium ions that replenish extracellular potassium stores and citrate ions that are metabolized to bicarbonate. The increased bicarbonate raises systemic pH, correcting metabolic acidosis, while urinary alkalinization reduces calcium precipitation, helping to prevent renal stone formation.

Side Effects

Potassium citrate is generally well tolerated, but adverse reactions can occur.

Common Side Effects

  • Gastrointestinal discomfort: nausea, abdominal cramping, or mild diarrhea.
  • Taste alteration: a sour or metallic mouthfeel.
  • Hyperkalemia: elevated serum potassium, especially in patients with renal impairment.
  • Metabolic alkalosis: excessive bicarbonate generation leading to high blood pH.

Serious or Rare Side Effects

  • Severe hyperkalemia: can cause cardiac arrhythmias and requires immediate medical attention.
  • Acute kidney injury: rare cases linked to excessive citrate load.
  • Allergic reactions: rash, itching, or swelling of the face and throat.
  • Metabolic acidosis worsening: paradoxical effect in very high doses.

Precautions & Warnings

Before prescribing Kacital, consider the following safety measures.

  • Renal function: assess kidney performance to avoid potassium accumulation.
  • Concomitant potassium‑sparing drugs: monitor serum potassium when used together.
  • Cardiac disease: patients with arrhythmias need close electrolyte monitoring.
  • Pregnancy and lactation: use only if the potential benefit outweighs risk, as data are limited.
  • Storage: Store at ambient temperature below 25°C: keep in the original container, protect from moisture and direct sunlight.

Avoid Interactions

Potassium citrate may interact with several medications; awareness helps prevent complications.

Major Interactions (Avoid)

  • ACE inhibitors or ARBs combined with potassium‑sparing diuretics: risk of severe hyperkalemia.
  • Digoxin: elevated potassium can reduce digoxin toxicity but may also mask toxicity signs.

Moderate Interactions (Monitor Closely)

  • Loop or thiazide diuretics: may increase potassium loss, requiring dose adjustment.
  • NSAIDs: can impair renal potassium excretion, raising serum levels.
  • Antacids containing aluminum or magnesium: may affect citrate absorption.

Frequently Asked Questions

Kacital contains potassium citrate and is used to treat low blood potassium (hypokalemia), help prevent kidney stones by alkalinizing urine, and correct metabolic acidosis by providing citrate that is converted to bicarbonate.

After oral intake, potassium citrate dissociates into potassium and citrate. Potassium restores extracellular potassium levels, while citrate is metabolized to bicarbonate, raising systemic pH and making urine less acidic, which reduces calcium stone formation.

The appropriate dose of Kacital is determined by the prescribing healthcare professional based on the patient’s condition, laboratory values, and clinical response. Dosage regimens are individualized and should not be altered without medical guidance.

Safety data for potassium citrate in pregnancy and lactation are limited. It should be used only if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and under close medical supervision.

To order Kacital, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Unlike simple potassium chloride, potassium citrate also provides citrate, which can alkalinize urine and correct metabolic acidosis. This dual action makes it useful for patients needing both potassium repletion and urine pH management, whereas other potassium salts lack the citrate component.

Store Kacital at ambient temperature below 25 °C. Keep the product in its original packaging, protect it from moisture and direct sunlight, and ensure the container is tightly closed to maintain stability.

Kacital is taken orally, usually as a solution or powder that is dissolved in water before ingestion. The exact method of preparation and timing relative to meals should follow the prescribing clinician’s instructions.

The most serious risks include severe hyperkalemia, which can cause cardiac arrhythmias, and metabolic alkalosis. Patients with impaired kidney function or those taking other potassium‑raising drugs are at higher risk and require close monitoring.

Kacital should be avoided in patients with known hypersensitivity to potassium citrate, severe renal impairment, uncontrolled hyperkalemia, or in those taking multiple potassium‑sparing medications without appropriate monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Potassium Citrate

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT